Diagnostic Criteria for Central Diabetes Insipidus
Central diabetes insipidus (now termed arginine vasopressin deficiency, AVP-D) is diagnosed when hypotonic urine (<300 mOsm/kg), hypernatremia (>147 mmol/L), plasma hyperosmolality (>280 mOsm/kg), and collapsed copeptin (≤4.9 pmol/L) occur together in the presence of clear clinical manifestations of polyuria and polydipsia 1.
Core Diagnostic Criteria
The diagnosis requires the simultaneous presence of:
Biochemical Parameters
- Urine osmolality: <300 mOsm/kg (inappropriately dilute relative to plasma)
- Serum sodium: >147 mmol/L
- Plasma osmolality: >280 mOsm/kg
- Copeptin level: ≤4.9 pmol/L 1
Clinical Presentation
- Polyuria: Large volumes of dilute urine
- Polydipsia: Excessive thirst (except in adipsic variants)
- In children: May present with failure to thrive, hypernatremic dehydration 2
Diagnostic Algorithm
Step 1: Initial Screening
When polyuria-polydipsia syndrome is suspected, measure simultaneously:
- Serum sodium and osmolality
- Urine osmolality
- If available, baseline copeptin
Key finding: Inappropriately diluted urine (osmolality <200-300 mOsm/kg) with high-normal or elevated serum sodium is pathognomonic for diabetes insipidus (either central or nephrogenic) 2.
Step 2: Distinguish Central from Nephrogenic DI
If copeptin measurement is available (preferred approach):
- Baseline copeptin >21.4 pmol/L: Confirms nephrogenic DI 2
- Baseline copeptin ≤4.9 pmol/L with hypernatremia: Confirms complete central DI 1
- Intermediate copeptin values: Proceed to stimulation testing
Stimulation testing (when baseline copeptin is indeterminate):
- Hypertonic saline infusion: Copeptin <4.9 pmol/L after stimulation confirms central DI (highest diagnostic accuracy) 1, 3, 4
- Requires hospitalization and sodium monitoring every 30 minutes
- Superior to water deprivation test but poor clinical tolerance 1
- Arginine infusion: Alternative with better tolerance, slightly lower diagnostic accuracy 3, 4
If copeptin unavailable (traditional approach):
- Water deprivation test followed by desmopressin administration
Step 3: Etiological Investigation
Once central DI is biochemically confirmed, determine the underlying cause:
Neuroimaging (MRI of hypothalamic-pituitary region):
- Evaluate for structural abnormalities:
Important caveat: Absence of physiological posterior pituitary T1 hyperintensity does NOT contribute to AVP-D diagnosis, as it is absent in 10% of healthy individuals 1.
Additional investigations:
- Assess for other pituitary hormone deficiencies (common in congenital forms)
- In children with suspected germ cell tumors: Measure serum and CSF AFP and βHCG 7
- Consider genetic testing in congenital/familial cases 1
Critical Pitfalls to Avoid
Do not rely solely on absence of posterior pituitary bright spot on MRI - this finding is non-specific 1
Distinguish from adipsic central DI: Patients may not be thirsty and can present with persistent hypernatremia without polyuria, making diagnosis particularly challenging 8
Post-surgical context: After transsphenoidal surgery, transient AVP-D occurs in 17% and permanent in 3% of pituitary adenoma cases (much higher in craniopharyngiomas at 30-31%) 9. Diagnosis requires same biochemical criteria but clinical context differs.
Partial central DI: May have less dramatic biochemical abnormalities, making distinction from primary polydipsia difficult without stimulation testing 2, 5
Water deprivation test limitations: Can misclassify patients, has long duration (17 hours), and is poorly tolerated - copeptin-based testing is superior when available 3, 4
Special Populations
Pediatric patients: Same diagnostic criteria apply, but presentation often includes failure to thrive and hypernatremic dehydration episodes. Early diagnosis is critical to prevent seizures, developmental delay, and cognitive impairment 2, 6.
Idiopathic cases: Require close follow-up as central DI can be the first manifestation of underlying pathology (tumors, infiltrative disease) that may only become apparent over time 10, 6.